Product image of Irbotens Plus (Hydrochlorothiazide, Irbesartan) supplied by GNH India

Irbotens Plus

Active Ingredient:
Hydrochlorothiazide, Irbesartan
Origin:
EU

Irbotens Plus (Hydrochlorothiazide, Irbesartan)

Hydrochlorothiazide / Irbesartan, the active ingredient in Irbotens Plus, is a Angiotensin II receptor blocker (ARB) and thiazide diuretic combination presented as an oral tablet for oral use. It treats hypertension in adult patients.
GNH India supplies Irbotens Plus as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Vian S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Irbotens Plus is an antihypertensive medication that works within the renin‑angiotensin‑aldosterone system to lower blood pressure.
  • Hypertension: reduces systolic and diastolic pressure and lowers cardiovascular risk.
  • Essential hypertension: provides consistent blood‑pressure control when monotherapy is insufficient.
  • Hypertension with fluid retention: adds diuretic effect to improve volume management.

How It Works

  • Irbesartan selectively blocks the AT1 receptor, preventing angiotensin II‑mediated vasoconstriction and aldosterone release, while hydrochlorothiazide inhibits NaCl reabsorption in the distal convoluted tubule, promoting diuresis and reducing plasma volume. The combined actions result in decreased peripheral resistance and lowered blood pressure.

Side Effects

Common Side Effects

  • Dizziness or light‑headedness
  • Headache
  • Fatigue or weakness
  • Increased urination
  • Electrolyte disturbances (e.g., low potassium)
  • Mild gastrointestinal upset

Serious or Rare Side Effects

  • Severe dehydration or electrolyte imbalance
  • Hyperkalemia
  • Angioedema or swelling of face, lips, tongue
  • Acute kidney injury
  • Severe hypotension
  • Allergic skin reactions such as Stevens‑Johnson syndrome

Precautions & Warnings

Irbotens Plus requires careful monitoring and patient education before and during therapy.

  • Blood pressure monitoring: check regularly to avoid excessive hypotension.
  • Electrolyte assessment: monitor potassium and sodium levels, especially in patients on other diuretics.
  • Renal function: evaluate creatinine and eGFR before initiation and periodically thereafter.
  • Use with caution in elderly patients due to increased risk of orthostatic hypotension.
  • Avoid in patients with severe hepatic impairment unless benefits outweigh risks.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Irbotens Plus can interact with several medicines that affect blood pressure, electrolytes, or renal function.

Major Interactions (Avoid)

  • Aliskiren: combined use may increase risk of renal impairment and hyperkalemia.
  • Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia.
  • Lithium: can increase lithium levels and toxicity.
  • ACE inhibitors: concurrent use may raise risk of angioedema and renal dysfunction.
  • NSAIDs: may blunt antihypertensive effect and worsen renal function.

Moderate Interactions (Monitor Closely)

  • Other antihypertensives: may require dose adjustments to prevent hypotension.
  • Antidiabetic agents: blood‑glucose control may improve, risking hypoglycemia.
  • Digoxin: monitor serum levels as diuretic‑induced electrolyte changes can affect toxicity.
  • Corticosteroids: may increase sodium retention, counteracting diuretic effect.
  • Antimicrobials such as trimethoprim‑sulfamethoxazole: can raise potassium levels.

Frequently Asked Questions

Irbotens Plus is prescribed to lower high blood pressure in adult patients. It combines an angiotensin II receptor blocker with a thiazide diuretic, providing dual mechanisms that reduce vascular resistance and decrease fluid volume, helping to achieve target blood‑pressure levels and reduce cardiovascular risk.

Irbesartan blocks the AT1 receptor, preventing angiotensin II from causing vasoconstriction and aldosterone release. Hydrochlorothiazide acts on the distal convoluted tubule to inhibit sodium‑chloride reabsorption, increasing urine output and lowering plasma volume. Together they lower systemic vascular resistance and blood volume, resulting in reduced blood pressure.

The appropriate dose of Irbotens Plus is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concomitant medications. Dosage adjustments are individualized and should follow the prescriber’s instructions and local regulatory guidelines.

Safety of Irbotens Plus in pregnancy or while breastfeeding has not been established. Healthcare providers usually avoid prescribing it to pregnant or nursing women unless the potential benefit justifies the potential risk. Patients should discuss any concerns with their physician.

To request Irbotens Plus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Irbotens Plus offers a fixed‑dose combination of an ARB and a thiazide diuretic, which can simplify therapy compared with taking two separate agents. This may improve adherence and provide synergistic blood‑pressure reduction, whereas monotherapy with either class alone may be less effective in patients needing dual mechanisms.

Irbotens Plus tablets should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Irbotens Plus is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water and do not crush or chew it unless specifically instructed by a healthcare professional.

Serious risks include severe dehydration, electrolyte imbalances such as hyperkalemia, acute kidney injury, and angioedema. Patients should report symptoms like rapid weight loss, muscle weakness, swelling of the face or throat, or a sudden drop in urine output to their healthcare provider promptly.

Irbotens Plus is contraindicated in patients with known hypersensitivity to irbesartan, hydrochlorothiazide, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, anuria, or those taking prohibited drug combinations such as aliskiren in diabetic patients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydrochlorothiazide, Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT